Associated Papers
BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients.
Park JH et al.
Cancers, 2022
35008403 (PubMed )
Supplement: cancers-14-00236-s001.zip › cancers-1469089-supplementary.xlsx › supple_Table_S1
Select a paper to view details